CHRISTINA STEWART: Open Payments
NPI 1841508181 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 58 payments from 19 companies in 2025. Trend: 2023 $216 · 2024 $716 · 2025 $1,292
Food & beverage: $1,292
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $249 |
| Astellas Pharma US Inc | 6 | $153 |
| Abbott Laboratories | 6 | $130 |
| BETA BIONICS, INC. | 7 | $128 |
| Amgen Inc. | 5 | $87 |
| Novo Nordisk Inc | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Inspire Medical Systems, Inc. | 1 | $58 |
| Dexcom, Inc. | 2 | $46 |
Products named: Veozah, FREESTYLE LIBRE 3, iLet Bionic Pancreas, MOUNJARO, OTEZLA, SHINGRIX, INSPIRE, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
